-
1Dissertation/ Thesis
المؤلفون: Garrote Cámara, María Elena
المساهمون: University/Department: Universitat de Lleida. Departament d'Infermeria i Fisioteràpia
Thesis Advisors: Juárez Vela, Raúl, Santolalla Arnedo, Iván, Rubinat, Esther
المصدر: TDX (Tesis Doctorals en Xarxa)
مصطلحات موضوعية: Salut mental, Agitació psicomotriu, Trastorn mentals, Salud mental, Agitación psicomotora, Trastornos mentales, Mental health, Psychomotor agitation, Mental disorders, Infermeria
وصف الملف: application/pdf
URL الوصول: http://hdl.handle.net/10803/691365
-
2Report
المؤلفون: National Institute on Aging (NIA)
المساهمون: Dave Shade, Director, S-CitAD Coordinating Center
المصدر: Escitalopram for Agitation in Alzheimer's Disease
Ehrhardt S, Porsteinsson AP, Munro CA, Rosenberg PB, Pollock BG, Devanand DP, Mintzer J, Rajji TK, Ismail Z, Schneider LS, Baksh SN, Drye LT, Avramopoulos D, Shade DM, Lyketsos CG; S-CitAD Research Group. Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial. Alzheimers Dement. 2019 Nov;15(11):1427-1436. doi: 10.1016/j.jalz.2019.06.4946. Epub 2019 Oct 3. -
3Report
المصدر: A Phase 2a, Multicenter, Placebo-controlled, Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia
-
4Report
المؤلفون: Worldwide Clinical Trials
المصدر: Efficacy And Safety of BXCL501 Evaluated For At-Home Use In A Multisite Double-Blind Placebo-Controlled Trial For Agitation Associated With Schizophrenia And Bipolar Disorder
-
5Report
المؤلفون: Medical University of South Carolina, Alzheimer's Clinical Trials Consortium, Alzheimer's Therapeutic Research Institute, National Institute on Aging (NIA)
المساهمون: Paul S. Aisen, Professor
المصدر: Life's End Benefits of cannaBidiol and tetrahYdrocannabinol (LiBBY)
-
6Report
المصدر: A Phase 3, Multicenter, Long Term, Extension Study of the Safety and Efficacy of AVP-786 (Deuterated [d6] Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Other URLs: https://clinical-trials.otsuka.com
-
7Report
المصدر: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Other URLs: https://clinical-trials.otsuka.com
-
8Report
المصدر: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Other URLs: https://clinical-trials.otsuka.com
-
9Report
المصدر: An Open-Label and Double-Blind, Randomized Withdrawal Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Dementia of the Alzheimer's Type
-
10Report
المصدر: ADVANCE-2: Addressing Dementia Via Agitation-Centered Evaluation 2: a Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Alzheimer's Disease Agitation
-
11Report
المساهمون: Bernard (Barry) Baumel, Associate Professor of Neurology
المصدر: A Pilot Study to Assess the Effect of Adding 1 Infusion of Human Mesenchymal Stem Cells (hMSC) to the Treatment of Patients Suffering Agitation/Aggression or Other Behavioral Abnormalities From Alzheimer's Disease.
-
12Report
المصدر: A Phase 1b, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease
-
13Report
المصدر: A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants With Dementia Due to Alzheimer's Disease
-
14Report
المؤلفون: Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Capital Region's Pharmacy (Region Hovedstadens Apotek), Marielundvej 25, 2730 Herlev, Denmark
المساهمون: Lone Baandrup, Head of Clinic, clinical associate research professor
المصدر: Advancing the Quality of Treatment and Care for Acute Agitation in Emergency Psychiatry
-
15Report
المصدر: Nabilone for Agitation Blinded Intervention Trial
Herrmann N, Ruthirakuhan M, Gallagher D, Verhoeff NPLG, Kiss A, Black SE, Lanctot KL. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease. Am J Geriatr Psychiatry. 2019 Nov;27(11):1161-1173. doi: 10.1016/j.jagp.2019.05.002. Epub 2019 May 8. -
16Report
المصدر: Effects of PNF Stretching vs Conventional Physical Therapy on the Symptoms of Restless Leg Syndrome in Elderly Population.
-
17Report
المصدر: An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects with Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study
-
18Report
المساهمون: Bomi Framroze, Principal Investigator
المصدر: Gene Expression Changes on Extended Use of Dopamine Agonists in Restless Legs Syndrome (RLS)
-
19Periodical
المؤلفون: BENDLE, MERVYN
المصدر: Quadrant Magazine. Sep2024, Vol. 68 Issue 9, p52-57. 6p.
مصطلحات موضوعية: *ANXIETY, *AGITATION (Psychology), *MORTALITY, *DEMOGRAPHY, *DEATH
-
20Report
المساهمون: Emmanuel Mignot, Craig Reynolds Professor of Sleep Medicine
المصدر: Proteomic Response to Exercise in Adults With Restless Legs Syndrome